United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022

August 2017 | 130 pages | ID: U3DFEF52FEFEN
DPI Research

Abstracts

United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022

Contents

1. EXECUTIVE SUMMARY

2. BREAST CANCER FACTS

3. UNITED STATES BREAST CANCER CASES & POPULATION (2010 – 2022)

3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
3.2 Breast Cancer Occurrence (2010–2022)
  3.2.1 Total Breast Cancer Cases
    3.2.1.1 Breast Cancer Invasive Cases
    3.2.1.2 Breast Cancer In Situ Cases
    3.2.1.3 Breast Cancer Men Cases
3.3 Breast Cancer Death (2010 – 2017)
  3.3.1 Total Breast Cancer Death
    3.3.1.1 Women Breast Cancer Death
    3.3.1.2 Men Breast Cancer Death

4. MARKET OVERVIEW: UNITED STATES BREAST CANCER SCREENING (2010 – 2022)

5. MARKET SHARE: UNITED STATES BREAST CANCER SCREENING (2010 – 2022)

6. BY TYPES: MARKET SIZE & ANALYSIS (2010 – 2022)

6.1 Mammography Screening Market
6.2 Breast Magnetic Resonance Imaging (MRI) Screening Market
6.3 Breast Ultrasound Screening Market

7. KEY DRIVERS AND INHIBITORS OF THE UNITED STATES BREAST CANCER SCREENING MARKET

7.1 Market Drivers
7.2 Market Inhibitors

8. REIMBURSEMENT POLICIES OF THE UNITED STATES BREAST CANCER SCREENING

8.1 Mammography
8.2 Breast Magnetic Resonance Imaging(MRI)
8.3 Breast Ultrasound

9. BREAST CANCER SCREENING MARKET CLINICAL TRAIL INSIGHT BY PHASE, COMPANY & COUNTRY

9.1 Year 2017
9.2 Year 2016
9.3 Year 2015

10. KEY MANUFACTURERS ANALYSIS

10.1 Hologic
  10.1.1 Business Overview
  10.1.2 Breast Cancer Screening – Marketed Products
    10.1.2.1 Mammography
    10.1.2.2 Magnetic Resonance Imaging(MRI)
  10.1.3 Breast Cancer Screening – Latest Development & Trends
10.2 Hitachi Medical Corporation
  10.2.1 Business Overview
  10.2.2 Breast Cancer Screening – Marketed Products
    10.2.2.1 Magnetic Resonance Imaging(MRI)
    10.2.2.2 Ultrasound
  10.2.3 Breast Cancer Screening – Latest Development & Trends
10.3 Siemens Healthineers
  10.3.1 Business Overview
  10.3.2 Breast Cancer Screening – Marketed Products
    10.3.2.1 Mammography
    10.3.2.2 Magnetic Resonance Imaging (MRI)
  10.3.3 Breast Cancer Screening – Latest Development & Trends
10.4 Philips Healthcare
  10.4.1 Business Overview
  10.4.2 Breast Cancer Screening – Marketed Products
    10.4.2.1 Mammography
    10.4.2.2 Magnetic Resonance Imaging (MRI)
    10.4.2.3 Ultrasound
  10.4.3 Breast Cancer Screening – Latest Development & Trends
10.5 Toshiba Medical Systems Corporation
  10.5.1 Business Overview
  10.5.2 Breast Cancer Screening – Marketed Products
    10.5.2.1 Mammography
    10.5.2.2 Magnetic Resonance Imaging (MRI)
    10.5.2.3 Ultrasound
  10.5.3 Breast Cancer Screening – Latest Development & Trends
10.6 GE Healthcare
  10.6.1 Business Overview
  10.6.2 Breast Cancer Screening – Marketed Products
    10.6.2.1 Mammography
    10.6.2.2 Magnetic Resonance Imaging (MRI)
    10.6.2.3 Ultrasound
  10.6.3 Breast Cancer Screening – Latest Development & Trends

List Of Tables

LIST OF TABLES:

Table 5–1: United States – Breast Cancer Screening Market Share(Percent),2010 – 2016
Table 5–2: United States – Forecast for Breast Cancer Screening Market Share(Percent),2017 – 2022

List Of Figures

LIST OF FIGURES:

Figure 3–1: United States – Breast Cancer Mammography Screening Population(Thousand),2010 – 2016
Figure 3–2: United States – Breast Cancer Mammography Screening Population(Thousand),2017 – 2022
Figure 3–3: United States – Total Breast Cancer Cases(Number),2010 – 2016
Figure 3–4: United States – Forecast for Total Breast Cancer Cases(Number),2017 – 2022
Figure 3–5: United States – Breast Cancer Invasive Cases(Number),2010 – 2016
Figure 3–6: United States – Forecast for Breast Cancer Invasive Cases(Number),2017 – 2022
Figure 3–7: United States – Breast Cancer In Situ Cases(Number),2010 – 2016
Figure 3–8: United States – Forecast for Breast Cancer In Situ Cases(Number),2017 – 2022
Figure 3–9: United States – Breast Cancer Men Cases(Number),2010 – 2016
Figure 3–10: United States – Forecast for Breast Cancer Men Cases(Number),2017 – 2022
Figure 3–11: United States – Total Breast Cancer Death(Number),2010 – 2017
Figure 3–12: United States – Women Breast Cancer Death(Number),2010 – 2017
Figure 3–13: United States – Men Breast Cancer Death(Number),2010 – 2017
Figure 4–1: United States – Breast Cancer Screening Market (Million US$),2010 – 2016
Figure 4–2: United States – Forecast for Breast Cancer Screening Market (Million US$),2017 – 2022
Figure 6–1: United States – Mammography Screening Market (Million US$),2010 – 2016
Figure 6–2: United States – Forecast for Mammography Screening Market (Million US$),2017 – 2022
Figure 6–3: United States – MRI Screening Market (Million US$),2010 – 2016
Figure 6–4: United States – Forecast for MRI Screening Market (Million US$),2017 – 2022
Figure 6–5: United States – Breast Ultrasound Screening Market (Million US$),2010 – 2016
Figure 6–6: United States – Breast Ultrasound Screening Market (Million US$),2017 – 2022